Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Understanding public perceptions of benefits and risks of childhood vaccinations in the United States.

Song G.

Risk Anal. 2014 Mar;34(3):541-55. doi: 10.1111/risa.12114. Epub 2013 Sep 13.

PMID:
24033739
2.

Vanishing vaccinations: why are so many Americans opting out of vaccinating their children?

Calandrillo SP.

Univ Mich J Law Reform. 2004 Winter;37(2):353-440.

PMID:
15568260
3.

Value predispositions as perceptual filters: Comparing of public attitudes toward nanotechnology in the United States and Singapore.

Liang X, Ho SS, Brossard D, Xenos MA, Scheufele DA, Anderson AA, Hao X, He X.

Public Underst Sci. 2015 Jul;24(5):582-600. doi: 10.1177/0963662513510858. Epub 2013 Nov 28.

PMID:
24292230
4.

Risk perception, risk management and safety assessment: what can governments do to increase public confidence in their vaccine system?

MacDonald NE, Smith J, Appleton M.

Biologicals. 2012 Sep;40(5):384-8. doi: 10.1016/j.biologicals.2011.08.001. Epub 2011 Oct 10.

PMID:
21993306
5.

Disentangling the influence of value predispositions and risk/benefit perceptions on support for nanotechnology among the American public.

Kim J, Yeo SK, Brossard D, Scheufele DA, Xenos MA.

Risk Anal. 2014 May;34(5):965-80. doi: 10.1111/risa.12141. Epub 2013 Nov 6.

PMID:
24200237
6.

A crisis of public confidence in vaccines.

Black S, Rappuoli R.

Sci Transl Med. 2010 Dec 8;2(61):61mr1. doi: 10.1126/scitranslmed.3001738.

PMID:
21148125
7.

Knowledge, attitudes, and beliefs of school nurses and personnel and associations with nonmedical immunization exemptions.

Salmon DA, Moulton LH, Omer SB, Chace LM, Klassen A, Talebian P, Halsey NA.

Pediatrics. 2004 Jun;113(6):e552-9.

PMID:
15173536
8.

Fairness and nanotechnology concern.

McComas KA, Besley JC.

Risk Anal. 2011 Nov;31(11):1749-61. doi: 10.1111/j.1539-6924.2011.01676.x. Epub 2011 Aug 29.

PMID:
21883336
9.

Perceptions of risk and optimistic bias for acute gastrointestinal illness: a population survey.

Sargeant JM, Majowicz SE, Sheth U, Edge VL.

Zoonoses Public Health. 2010 Dec;57(7-8):e177-83. doi: 10.1111/j.1863-2378.2010.01325.x.

PMID:
20202184
10.

Parental perceptions surrounding risks and benefits of immunization.

Gust DA, Woodruff R, Kennedy A, Brown C, Sheedy K, Hibbs B.

Semin Pediatr Infect Dis. 2003 Jul;14(3):207-12.

PMID:
12913833
11.

Evolving public perceptions and stability in vaccine uptake.

Reluga TC, Bauch CT, Galvani AP.

Math Biosci. 2006 Dec;204(2):185-98. Epub 2006 Aug 26.

PMID:
17056073
12.

Anticipating the perceived risk of nanotechnologies.

Satterfield T, Kandlikar M, Beaudrie CE, Conti J, Herr Harthorn B.

Nat Nanotechnol. 2009 Nov;4(11):752-8. doi: 10.1038/nnano.2009.265. Epub 2009 Sep 20. Erratum in: Nat Nanotechnol. 2009 Dec;4(12):883.

PMID:
19893527
13.

Perceived risk of nuclear power and other risks during the last 25 years in Japan.

Kanda R, Tsuji S, Yonehara H.

Health Phys. 2012 Apr;102(4):384-90. doi: 10.1097/HP.0b013e31823abef2.

PMID:
22378199
14.

Weighing the risks and benefits of vaccination.

Glickman LT.

Adv Vet Med. 1999;41:701-13. Review.

PMID:
9890055
15.

Public attitudes and risk perception toward land application of biosolids within the south-eastern United States.

Robinson KG, Robinson CH, Raup LA, Markum TR.

J Environ Manage. 2012 May 15;98:29-36. doi: 10.1016/j.jenvman.2011.12.012. Epub 2012 Jan 11.

PMID:
22325641
16.

A cross-cultural study of perceived benefit versus risk as mediators in the trust-acceptance relationship.

Bronfman NC, Vázquez EL.

Risk Anal. 2011 Dec;31(12):1919-34. doi: 10.1111/j.1539-6924.2011.01637.x. Epub 2011 May 23.

PMID:
21605152
17.

Understanding attitudes toward clinical research.

Schulman KA.

J Ambul Care Manage. 2003 Jan-Mar;26(1):88-90.

PMID:
12545518
18.

The influence of vaccine-critical websites on perceiving vaccination risks.

Betsch C, Renkewitz F, Betsch T, Ulshöfer C.

J Health Psychol. 2010 Apr;15(3):446-55. doi: 10.1177/1359105309353647.

PMID:
20348365
19.

Vulnerability and social justice as factors in emergent U.S. nanotechnology risk perceptions.

Conti J, Satterfield T, Harthorn BH.

Risk Anal. 2011 Nov;31(11):1734-48. doi: 10.1111/j.1539-6924.2011.01608.x. Epub 2011 Mar 31.

PMID:
21453374
20.

Immunization coverage levels among 19- to 35-month-old children in 4 diverse, medically underserved areas of the United States.

Rosenthal J, Rodewald L, McCauley M, Berman S, Irigoyen M, Sawyer M, Yusuf H, Davis R, Kalton G.

Pediatrics. 2004 Apr;113(4):e296-302.

PMID:
15060256

Supplemental Content

Support Center